Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

804 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins.
De Berardis G, Sacco M, Evangelista V, Filippi A, Giorda CB, Tognoni G, Valentini U, Nicolucci A; ACCEPT-D Study Group. De Berardis G, et al. Among authors: tognoni g. Trials. 2007 Aug 28;8:21. doi: 10.1186/1745-6215-8-21. Trials. 2007. PMID: 17725825 Free PMC article.
Impact of physicians' beliefs and practices on cholesterol levels in patients with type 2 diabetes: a longitudinal assessment.
Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Di Nardo B, Greenfield S, Kaplan SH, Rossi MC, Sacco M, Tognoni G, Valentini M, Nicolucci A; Quality of Care and Outcomes in Type 2 Diabetes (QuED) Study Group. Franciosi M, et al. Among authors: tognoni g. Am Heart J. 2005 Jan;149(1):104-11. doi: 10.1016/j.ahj.2004.06.011. Am Heart J. 2005. PMID: 15660041
Quality of diabetes care predicts the development of cardiovascular events: results of the QuED study.
De Berardis G, Pellegrini F, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, Kaplan SH, Rossi MC, Sacco M, Tognoni G, Valentini M, Nicolucci A; QuED (Quality of Care and Outcomes in Type 2 Diabetes) Study Group. De Berardis G, et al. Among authors: tognoni g. Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):57-65. doi: 10.1016/j.numecd.2006.04.009. Epub 2006 Jul 24. Nutr Metab Cardiovasc Dis. 2008. PMID: 16860547
Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study.
Franciosi M, Pellegrini F, Sacco M, De Berardis G, Rossi MC, Strippoli GF, Belfiglio M, Tognoni G, Valentini M, Nicolucci A; IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group. Franciosi M, et al. Among authors: tognoni g. Clin J Am Soc Nephrol. 2007 Sep;2(5):984-91. doi: 10.2215/CJN.01190307. Epub 2007 Aug 5. Clin J Am Soc Nephrol. 2007. PMID: 17702724
Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol.
Strippoli GF; Clinical Evaluation of the DOse of Erythropoietins Study Group (C.E. DOSE). Strippoli GF, et al. Trials. 2010 Jun 9;11:70. doi: 10.1186/1745-6215-11-70. Trials. 2010. PMID: 20534124 Free PMC article. Clinical Trial.
804 results